Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections

This publication has 11 references indexed in Scilit:

• Urinary Recovery of N -Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N -Formimidoyl Thienamycin Dehydropeptidase Inhibitors
  Antimicrobial Agents and Chemotherapy, 1983
• Activity of imipenem on aerobic bacteria
  Journal of Antimicrobial Chemotherapy, 1983
• Pseudomonas aeruginosa and Acinetobacter calcoaceticus: In vitro Susceptibility of 150 Clinical Isolates to Five β-Lactam Antibiotics and Tobramycin
  Chemotherapy, 1983
• Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I
  Antimicrobial Agents and Chemotherapy, 1982
• Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin
  Antimicrobial Agents and Chemotherapy, 1982
• Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability
  Antimicrobial Agents and Chemotherapy, 1982
• In vitro Comparative Activity of Moxalactam, GR 20263, and N-Formimidoyl Thienamycin to Other Beta-Lactam Antibiotics and Tobramycin against Enterobacteriaceae and Staphylococci
  Chemotherapy, 1982
• Susceptibility of Gram-Positive Cocci to Various Antibiotics, Including Cefotaxime, Moxalactam, and N -Formimidoyl Thienamycin
  Antimicrobial Agents and Chemotherapy, 1981
• Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside
  Antimicrobial Agents and Chemotherapy, 1981
• Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa
  Antimicrobial Agents and Chemotherapy, 1980